A Melanocortin-4 Receptor Agonist Induces Skin and Hair Pigmentation in Patients with Monogenic Mutations in the Leptin-Melanocortin PathwayVarvara Kanti, Ulrike Blume‐Peytavi, Lia Puder et al.|Skin Pharmacology and Physiology|2021Cited by 36
Early-set POMC methylation variability is accompanied by increased risk for obesity and is addressable by MC4R agonist treatmentLara Lechner, Peter Kühnen, Andrew M. Prentice et al.|Science Translational Medicine|2023Cited by 17